Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/10/2022 → 30/09/2026 |
Funding
- Viewpoint Molecular Targeting, Inc.: £53,685.58
Development, radiobiological assessment and dosimetry of radiopharmaceuticals emitting alpha and beta particlesa and beta particle-emitters
- Terry, Samantha (Primary Investigator)
- Stasiuk, Graeme (Co-Investigator)
Project: Research